Analytical Data
-
基因名
BTBD11
- Application
-
别名
BTBD11; Ankyrin repeat and BTB/POZ domain-containing protein BTBD11; BTB/POZ domain-containing protein 11
-
种属
Human
-
表达系统
Baculovirus
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A6QL63
-
表达区间
A2-V1104
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BTBD11 (BTB domain containing 11) is a member of the BTB/POZ protein family, which is known to play significant roles in various biological processes, including gene regulation, protein-protein interactions, and the assembly of multiprotein complexes. Recent studies have highlighted its involvement in essential cellular functions and its potential implications in human diseases, particularly in the context of cancer and developmental disorders. Research has shown that BTBD11 can act as a transcriptional regulator, influencing gene expression patterns critical for cell differentiation and proliferation. Additionally, dysregulation of BTBD11 has been associated with oncogenic pathways, making it a candidate for further investigation as a therapeutic target. Given its intriguing structural features and functional versatility, the recombinant production of BTBD11 protein has become a focal point in the field of molecular biology, allowing for in-depth studies into its biochemical properties and interactions with other cellular components. Understanding the functional mechanisms of BTBD11 through recombinant protein studies may shed light on its role in various pathophysiological conditions and contribute to the development of novel therapeutic strategies.
